← brief for 2026-09-29 · Slowing decline

Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes.

Article B Peer reviewed Small trial

Key takeaways

This small study looked at 16 people with type 2 diabetes who took a drug called semaglutide. The researchers found that the drug lowered the number of certain immune cells in the blood. These cells can cause inflammation, which can hurt the heart and kidneys. The study was very small, so it cannot prove the drug works for everyone.

Who did this work

Teunis CJ · Collins TJC · Oostveen RF · Neele AE · de Winther M · Nurmohamed NS · Heijmans J · Winkelmeijer M · Dzobo KE · Cooper ME · van Raalte DH · Nieuwdorp M

Source

Article · PubMed, the drug frontier · 2026 Sep 29
https://pubmed.ncbi.nlm.nih.gov/42806711/